Ani Pharmaceuticals

ANIPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.789 B

$77.91 -1.19%

Close of 22 Sept 2026

Revenue

$883.4M

#1590 by revenue

Earnings

$78.0M

#1401 by earnings

Shares outstanding

22,491,281

Latest filing cover page

P/E ratio

22.9

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#118Stoke TherapeuticsSTOK$1.88B
#119XencorXNCR$1.87B
#120Ani PharmaceuticalsANIP$1.79B
#121NanobiotixNBTX$1.79B
#122Tyra BiosciencesTYRA$1.76B

What if Ani Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,316,840

Per share 16,902× higher

Bitcoin $1.74T

$75,857.75

Per share 974× higher

Nvidia $5.52T

$240,239.11

Per share 3,084× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Ani Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.